| 000 | 01801 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516165801.0 | ||
| 264 | 0 | _c20141218 | |
| 008 | 201412s 0 0 eng d | ||
| 022 | _a1095-9572 | ||
| 024 | 7 |
_a10.1016/j.neuroimage.2013.08.031 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJiao, Jieqing | |
| 245 | 0 | 0 |
_aSpatio-temporal pharmacokinetic model based registration of 4D PET neuroimaging data. _h[electronic resource] |
| 260 |
_bNeuroImage _cJan 2014 |
||
| 300 |
_a225-35 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAlgorithms |
| 650 | 0 | 4 |
_aBrain _xdiagnostic imaging |
| 650 | 0 | 4 |
_aCarbon Isotopes _xpharmacokinetics |
| 650 | 0 | 4 | _aComputer Simulation |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImage Enhancement _xmethods |
| 650 | 0 | 4 |
_aImage Interpretation, Computer-Assisted _xmethods |
| 650 | 0 | 4 |
_aImaging, Three-Dimensional _xmethods |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aModels, Neurological |
| 650 | 0 | 4 |
_aNeuroimaging _xmethods |
| 650 | 0 | 4 |
_aOxazines _xpharmacokinetics |
| 650 | 0 | 4 |
_aPositron-Emission Tomography _xmethods |
| 650 | 0 | 4 |
_aRadiopharmaceuticals _xpharmacokinetics |
| 650 | 0 | 4 |
_aReceptors, Dopamine D3 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aSpatio-Temporal Analysis |
| 650 | 0 | 4 | _aSubtraction Technique |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aSearle, Graham E | |
| 700 | 1 | _aTziortzi, Andri C | |
| 700 | 1 | _aSalinas, Cristian A | |
| 700 | 1 | _aGunn, Roger N | |
| 700 | 1 | _aSchnabel, Julia A | |
| 773 | 0 |
_tNeuroImage _gvol. 84 _gp. 225-35 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neuroimage.2013.08.031 _zAvailable from publisher's website |
| 999 |
_c23049752 _d23049752 |
||